Logo image of AVGR

Avinger Inc (AVGR) Stock Fundamental Analysis

NASDAQ:AVGR - US0537348775 - Common Stock

0.474 USD
-0.12 (-20.74%)
Last: 2/14/2025, 8:21:08 PM
0.57 USD
+0.1 (+20.25%)
After Hours: 2/14/2025, 8:21:08 PM
Fundamental Rating

2

Taking everything into account, AVGR scores 2 out of 10 in our fundamental rating. AVGR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While AVGR seems to be doing ok healthwise, there are quite some concerns on its profitability. AVGR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AVGR has reported negative net income.
AVGR had a negative operating cash flow in the past year.
In the past 5 years AVGR always reported negative net income.
In the past 5 years AVGR always reported negative operating cash flow.
AVGR Yearly Net Income VS EBIT VS OCF VS FCFAVGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -127.59%, AVGR is doing worse than 89.89% of the companies in the same industry.
AVGR has a worse Return On Equity (-447.82%) than 86.70% of its industry peers.
Industry RankSector Rank
ROA -127.59%
ROE -447.82%
ROIC N/A
ROA(3y)-106.27%
ROA(5y)-96.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVGR Yearly ROA, ROE, ROICAVGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

1.3 Margins

With a Gross Margin value of 20.94%, AVGR is not doing good in the industry: 80.32% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of AVGR has grown nicely.
The Profit Margin and Operating Margin are not available for AVGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.35%
GM growth 5Y8.48%
AVGR Yearly Profit, Operating, Gross MarginsAVGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

4

2. Health

2.1 Basic Checks

AVGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AVGR has been increased compared to 1 year ago.
The number of shares outstanding for AVGR has been increased compared to 5 years ago.
AVGR has a worse debt/assets ratio than last year.
AVGR Yearly Shares OutstandingAVGR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
AVGR Yearly Total Debt VS Total AssetsAVGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -48.14, we must say that AVGR is in the distress zone and has some risk of bankruptcy.
AVGR has a Altman-Z score of -48.14. This is amonst the worse of the industry: AVGR underperforms 91.49% of its industry peers.
There is no outstanding debt for AVGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -48.14
ROIC/WACCN/A
WACC5.15%
AVGR Yearly LT Debt VS Equity VS FCFAVGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

2.3 Liquidity

A Current Ratio of 1.21 indicates that AVGR should not have too much problems paying its short term obligations.
The Current ratio of AVGR (1.21) is worse than 84.57% of its industry peers.
A Quick Ratio of 0.81 indicates that AVGR may have some problems paying its short term obligations.
With a Quick ratio value of 0.81, AVGR is not doing good in the industry: 88.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.81
AVGR Yearly Current Assets VS Current LiabilitesAVGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

AVGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.40%, which is quite impressive.
The Revenue has decreased by -6.30% in the past year.
Measured over the past years, AVGR shows a decrease in Revenue. The Revenue has been decreasing by -0.69% on average per year.
EPS 1Y (TTM)66.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.67%
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-4.41%
Revenue growth 5Y-0.69%
Sales Q2Q%-9.19%

3.2 Future

Based on estimates for the next years, AVGR will show a very strong growth in Earnings Per Share. The EPS will grow by 21.51% on average per year.
Based on estimates for the next years, AVGR will show a very strong growth in Revenue. The Revenue will grow by 27.27% on average per year.
EPS Next Y-30.64%
EPS Next 2Y29.28%
EPS Next 3Y21.51%
EPS Next 5YN/A
Revenue Next Year-12.9%
Revenue Next 2Y29.82%
Revenue Next 3Y29.14%
Revenue Next 5Y27.27%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVGR Yearly Revenue VS EstimatesAVGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
AVGR Yearly EPS VS EstimatesAVGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025 2026 -100K -200K -300K -400K -500K

1

4. Valuation

4.1 Price/Earnings Ratio

AVGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVGR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVGR Price Earnings VS Forward Price EarningsAVGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVGR Per share dataAVGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as AVGR's earnings are expected to grow with 21.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.28%
EPS Next 3Y21.51%

0

5. Dividend

5.1 Amount

No dividends for AVGR!.
Industry RankSector Rank
Dividend Yield N/A

Avinger Inc

NASDAQ:AVGR (2/14/2025, 8:21:08 PM)

After market: 0.57 +0.1 (+20.25%)

0.474

-0.12 (-20.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-18 2025-03-18/amc
Inst Owners1.73%
Inst Owner Change-99.56%
Ins Owners1.18%
Ins Owner Change0%
Market Cap1.57M
Analysts82.86
Price Target5.1 (975.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-265.43%
Min EPS beat(2)-542.96%
Max EPS beat(2)12.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.05%
Min Revenue beat(2)-29.02%
Max Revenue beat(2)-1.08%
Revenue beat(4)0
Avg Revenue beat(4)-19.68%
Min Revenue beat(4)-29.02%
Max Revenue beat(4)-1.08%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-11.03
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)-4.4
FCFYN/A
OCF(TTM)-4.4
OCFYN/A
SpS2.19
BVpS1.17
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -127.59%
ROE -447.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.94%
FCFM N/A
ROA(3y)-106.27%
ROA(5y)-96.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.35%
GM growth 5Y8.48%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.62%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.81
Altman-Z -48.14
F-Score4
WACC5.15%
ROIC/WACCN/A
Cap/Depr(3y)10.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.67%
EPS Next Y-30.64%
EPS Next 2Y29.28%
EPS Next 3Y21.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-4.41%
Revenue growth 5Y-0.69%
Sales Q2Q%-9.19%
Revenue Next Year-12.9%
Revenue Next 2Y29.82%
Revenue Next 3Y29.14%
Revenue Next 5Y27.27%
EBIT growth 1Y-10.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.16%
OCF growth 3YN/A
OCF growth 5YN/A